MA方案治疗初治急性髓系白血病34例疗效观察
SUZHOU UNIVERSITY JOURNAL OF MEDICAL SCIENCE（2004）
Abstract
将66例初治AML患者,随机分成两组进行诱导化疗.治疗组34例,采用MA方案(米托蒽醌+阿糖胞苷)诱导化疗;对照组32例,用DA方案诱导化疗.结果:治疗组34例中,25例取得完全缓解(CR),CR率为75.53%,其中1个疗程后CR19例,1个疗程CR率为76%.对照组32例中,16例CR,CR率50%,其中1个疗程后CR7例,1个疗程CR率为43.75%.两组CR率及1个疗程CR率有显著性差异(P＜0.05).结果表明,MA方案对初治AML有较好的疗效,其毒副作用可以耐受,可作为AML诱导化疗的首选方案之一.
MoreAI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined